The Texas Institute for Genomic Medicine (TIGM) is readu to include sales of mouse embryonic stem cell clones from the world’s largest collection of C57BL/6 and 129SvEv mouse lines. These mouse stem cell clones will be made available to scientists on a case by case basis.

TIGM maintains the world’s largest catalogue of embryonic stem cells for C57BL/6 mice, with more than 200,000 clones. In addition, TIGM has contracted access to the world’s largest catalog of genetically modified 129 mouse cells, with more than 272,000 stem cell clones available. TIGM uses these clones to create custom-designed breeding pairs of knockout mice that have specific genes altered especially for research.

TIGM is a not-for-profit institution created in 2005 to pioneer the development of life-changing medical breakthroughs, accelerate the pace of medical discoveries and to foster the development of the biotechnology industry in Texas. To that end, TIGM helps researchers worldwide gain faster, more cost-effective access to the genetically engineered knockout mice or mouse embryonic stem cells they need to help speed research to find the cure for human diseases and conditions.

source: TIGMA []